Gilead Sciences competitors

View the competitive landscape for Gilead, featuring companies like AstraZeneca, Lilly, and Biogen. Mapping a different industry? Browse our competitor database or generate a competitor list for any company.

Company icon
Gilead Sciences (Gilead)

Biopharmaceutical company focused on virology, oncology and inflammation

gilead.com

List of Gilead Sciences (Gilead) competitors

  • Company icon

    AstraZeneca

    Science-led biopharmaceutical company

    astrazeneca.com
  • Company icon

    Eli Lilly and Company (Lilly)

    Global biopharmaceutical company

    lilly.com
  • Company icon

    Biogen

    Biopharmaceutical company for neurological, immune, and rare diseases

    biogen.com
  • Company icon

    Novartis

    Innovative medicines company

    novartis.com
  • Company icon

    MSD

    Research-intensive biopharmaceutical company

    msd.com
  • Company icon

    Bristol Myers Squibb (BMS)

    Global biopharmaceutical company

    bms.com
  • Company icon

    GSK

    Global biopharmaceutical company

    gsk.com
  • Company icon

    Sanofi

    R&D-driven, AI-powered biopharmaceutical company

    sanofi.com
  • Company icon

    AbbVie

    Biopharmaceutical company

    abbvie.com
  • Company icon

    Amgen

    Multinational biopharmaceutical company

    amgen.com
  • Company icon

    Johnson & Johnson

    Diversified healthcare company developing treatments for infectious and inflammatory diseases

    jnj.com
  • Company icon

    Merck

    Research-intensive biopharmaceutical company

    merck.com
  • Company icon

    Pfizer

    Biopharmaceutical company

    pfizer.com
  • Company icon

    Regeneron

    Biopharmaceutical company

    regeneron.com
  • Company icon

    Roche

    Healthcare company specializing in pharmaceuticals and diagnostics for oncology

    roche.com
  • Company icon

    ViiV Healthcare

    Specialist company focused exclusively on HIV treatments and research

    viivhealthcare.com
Track Any Company’s News

Instantly get the news and insights that matter, sent straight to your inbox

Start your free trial